Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Pharmacokinetics and Safety
Age
0–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
This study will enroll pediatric and adult subjects with glaucoma or ocular hypertension receiving treatment with latanoprost in either one or both eyes for at least two weeks.
The pediatric subjects will be grouped by age (0 to \<3 years, 3 to \<12 years, 12 to 18 years).
You may not be if
Ocular inflammation/infection or a history of ocular inflammation/infection within 3 months prior to the screening visit.
History of ocular trauma or surgery in either eye within 14-days of the screening visit.
Use of continuous wear contact lenses.
Clareo Health | A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost.
